Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula

Autor: Rajat Datta, Peeyush K. Dhagat, Rajesh Vijayvergiya, Ankush Gupta, Sanya Chhikara
Rok vydání: 2020
Předmět:
0301 basic medicine
medicine.medical_specialty
NC
noncompliant
medicine.medical_treatment
LM
left main (coronary artery)
complication
030105 genetics & heredity
Asymptomatic
LAD
left anterior descending
03 medical and health sciences
0302 clinical medicine
BMS
bare metal stent(s)
mental disorders
Diseases of the circulatory (Cardiovascular) system
LA
left atrial
Medicine
Stent implantation
LCX
left circumflex
cardiovascular diseases
LV
left ventricular
Coronary artery aneurysm
PCI
percutaneous coronary intervention
DES
drug-eluting stent(s)
business.industry
Incidence (epidemiology)
percutaneous coronary intervention
CAA
coronary artery aneurysm
nutritional and metabolic diseases
Percutaneous coronary intervention
Mini-Focus Issue: Coronaries
medicine.disease
Bronchial Fistula
CT
computed tomography
Surgery
Drug-eluting stent
RC666-701
cardiovascular system
ECG
electrocardiogram
Case Report: Clinical Case
coronary angiography
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Complication
030217 neurology & neurosurgery
Zdroj: JACC Case Reports
JACC: Case Reports, Vol 2, Iss 11, Pp 1692-1697 (2020)
ISSN: 2666-0849
DOI: 10.1016/j.jaccas.2020.07.041
Popis: Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are asymptomatic. Hemoptysis as a presentation of CAA is very rare. The patient in our case had CAA after zotarolimus-eluting stent implantation and presented with hemoptysis resulting from a leaking coronary-bronchial fistula. (Level of Difficulty: Intermediate.)
Graphical abstract
Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are…
Databáze: OpenAIRE
Externí odkaz: